Clinical Trials Logo

Common Cold clinical trials

View clinical trials related to Common Cold.

Filter by:

NCT ID: NCT01677702 Completed - Common Cold Clinical Trials

Study of Yili Lactoferrin ShuHua Milk in the Improvement of Human Immunization

Start date: March 2011
Phase: N/A
Study type: Interventional

The purpose of this study is to determine whether Yili Lactoferrin ShuHua Milk are effective in reducing the occurrence of flu symptoms.

NCT ID: NCT01669603 Completed - Common Cold Clinical Trials

Effect of Probiotic on the Innate and Adaptive Host Response to Rhinovirus (EPIARR)

EPIARR
Start date: August 2012
Phase: N/A
Study type: Interventional

The study is designed to assess the effect of ingestion of a probiotic on innate and adaptive host responses to rhinovirus infection.

NCT ID: NCT01651715 Completed - Common Cold Clinical Trials

Efficacy and Safety Study of Homeopathic Oral Antibodies to Treat Viral Upper Respiratory Tract Infections

ESTUAR
Start date: September 2012
Phase: Phase 1/Phase 2
Study type: Interventional

The purpose of this study is to determine whether early self-treatment with homeopathic dilutions of oral antibodies to a key-protein of the immune system are effective and safe in the treatment of viral upper respiratory tract infections

NCT ID: NCT01651663 Recruiting - Influenza Clinical Trials

A Study of Arbidol (Umifenovir) for Treatment and Prophylaxis of Influenza and Common Cold

ARBITR
Start date: September 2011
Phase: Phase 4
Study type: Interventional

The purpose of this study is to determine whether Arbidol (Umifenovir) is effective in the treatment and Prophylaxis of Influenza and Common Cold

NCT ID: NCT01488604 Completed - Common Cold Clinical Trials

A Study of an Experimental Nasal Spray in Subjects With Early Signs of the Common Cold

Start date: January 2012
Phase: N/A
Study type: Interventional

This study will test 200 people to see if an experimental nasal spray has an effect on symptoms of the common cold if used when the symptoms start. At the first visit to the clinic, potential subjects will have tests to make sure they qualify to participate in the study. If they qualify, they will have an equal chance of receiving the experimental nasal spray or a sham nasal spray (one that does not have the experimental formula). At the first visit, subjects will receive their assigned nasal spray and use it once at the clinic. They will also receive a booklet called a diary. Subjects will take the rest of their treatments for day 1 at home, and for the next six days, they will use the nasal spray four times per day and record their symptoms in the diary, as instructed. Then subjects will come back to the clinic for a final visit.

NCT ID: NCT01466348 Completed - Common Cold Clinical Trials

Effects of a Common Cold Treatment on Cognitive Function

Start date: February 2011
Phase: Phase 4
Study type: Interventional

A reduction in alertness and lower levels of performance are commonly associated with the common cold. Paracetamol has been shown to be more effective than placebo in treating symptoms associated with upper respiratory tract infection; caffeine has been shown to increase levels of alertness and improve performance of people suffering from colds. This study will investigate any improvement in alertness and performance based on cognitive function and mood assessment in subjects suffering from the common cold, when taking a novel paracetamol and caffeine combination verses paracetamol alone.

NCT ID: NCT01465009 Completed - Common Cold Clinical Trials

Placebo and Active Controlled Study to Compare the Efficacy of Aspirin and Paracetamol in Treatment of Sore Throat Associated With a Common Cold

Start date: November 2003
Phase: Phase 4
Study type: Interventional

The purpose of this study is to determine the efficacy and safety of 1000 mg Aspirin (study medication) by comparing 1000 mg Paracetamol (study medication) in treating the symptoms of sore throat associated with a common cold. The study is designed to develop a treatment method against sore throat associated with a common cold which will have more advantages for patients than the methods that are currently available.

NCT ID: NCT01459952 Completed - Common Cold Clinical Trials

A Double-blind, Randomised, Parallel Group,Comparative Study With Rose-hip Liquid and Placebo Given to Healthy Volunteers in the Winter Season Aiming to Evaluate the Occurences of Flu and Catching a Cold

Start date: November 2011
Phase: Phase 3
Study type: Interventional

The trial is an investigator-initiated, double-blind, randomized, placebo-controlled phase III study. After the patient has receiving information about the study and after given written informed consent, the patient will be screened. The patient's medical history and demographic information will be recorded. The patient will then be asked questions in accordance to the study questionnaires, and they will also be asked to complete questionnaires regarding quality of life - and finally they be instructed on how to complete the diary. All patients are randomized to receive standardized rose hip liquid or matching placebo. The subject is instructed to take the liquid form of rose hips in the morning and evening meal. The subject will also be advised to call the clinic if there is an acute attack of cold and / or flu because they must then increase the in-take of study treatment to 3 double dose for 5 days and then return to normal dose. The subject will then be asked a series of questions under study questionnaires, and be instructed in how questionnaires (SF-12) and diary filled. This is to provide security to the validation output values Investigator or study nurse will take telephone contact with the subject once a month, subjects will be asked about how things are going and to remember to take the liquid and whether they have completed the diary. The last patient visit will take place after 6 months. Any side effects will be reported to and reviewed with HybenVital ApS in collaboration with medical experts.

NCT ID: NCT01439308 Completed - Rhinitis Clinical Trials

Intranasal SB-705498 in Non-allergic Rhinitis Patients

Start date: December 2009
Phase: Phase 2
Study type: Interventional

This study is designed to look at the affect of SB-705498 on rhinitis symptoms, as induced by capsaicin challenge

NCT ID: NCT01414335 Completed - Clinical trials for to Improve the Effectiveness of a Amino Acid Dietary Supplement in Chronic Pharyngeal Infections vs Placebo

Amino Acid Composition Reduces Frequency of Common Cold. Results of a Controlled Completely Masked Trial

Start date: October 2009
Phase: N/A
Study type: Interventional

The purpose of this study is to investigate the effectiveness of a dietary supplement with high dosage of amino acids and vitamins in the treatment of acute and chronic infection of pharyngeal area known as common cold. T